BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  RMS Medical Products Announces 2019 Second Quarter Financial Results

  Conference Call Scheduled for August 7 at 9:00 am ET

  August 6, 2019

   · 

  12 min read
• Biotech Beach

  Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row

  The Best System Performance award was presented to Beckman Coulter today at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, Calif.

  August 6, 2019

   · 

  4 min read
• Business

  Greenbrook TMS Continues Execution of Growth Strategy and Reports Record Second Quarter Financial Results

  All values in this news release are in United States dollars, unless otherwise stated.

  August 6, 2019

   · 

  8 min read
• Business

  Accredo’s New Full-Service Specialty Pharmacy Offers Hawaii Residents Greater Access to High-Touch Pharmacy Care

  Accredo opened a new, full-service pharmacy for residents of Hawaii who require additional clinical and administrative support for their complex treatments and medications.

  August 6, 2019

   · 

  4 min read
• 

  Drug Development

  Regeneron and Sanofi Eye Another Dupixent Approval Following Positive Trial Results

  The two companies will seek approval for the biologic as a treatment for severe atopic dermatitis in children ages six to 11.

  August 6, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Basilea Pharma’s Antibiotic Shows Non-inferiority in Late-Stage Trial

  Basilea Pharmaceutica, based in Basel, Switzerland, announced positive topline data from its Phase III TARGET study of deftobiprole for acute bacterial skin and skin structure infections.

  August 6, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Genetown

  LexaGene Nabs CDC and FDA Approval for New Antibiotic Resistance Test

  The CDC and FDA AR Isolate Bank will provide information to LexaGene which will support the company’s diagnostics development and help address the serious issue of antibiotic resistance.

  August 6, 2019

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  NIH Researcher Launches LUCA Biologics, a Company Dedicated to Microbiome Diseases and Women’s Health

  At this time, LUCA’s pipeline includes therapies for UTI, preterm birth and bacterial vaginosis.

  August 6, 2019

   · 

  2 min read

   · 

  Mark Terry
• 

  GSK Ends Efforts to Develop Ebola and Marburg Virus Vaccines, Transfers Tech to Sabin Institute

  The vaccines are for Ebola Zaire, Ebola Sudan and the Marburg virus. Currently no licensed vaccines against these three viruses are available. All three diseases have a death rate of about 50%.

  August 6, 2019

   · 

  3 min read

   · 

  Mark Terry
• 

  Mallinckrodt Delays Planned Generics Spin-Off Due to Opioid Litigation and Market Conditions

  Mallinckrodt said it remains committed to becoming an “innovation-driven specialty brands business.”

  August 6, 2019

   · 

  3 min read

   · 

  Alex Keown